AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Top Cited Papers
Open Access
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 11 (1) , 83-95
- https://doi.org/10.1016/j.ccr.2006.11.021
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Detection of Circulating Endothelial Cells: CD146-Based Magnetic Separation Enrichment or Flow Cytometric Assay?Journal of Clinical Oncology, 2007
- Tumor Stromal-Derived Factor-1 Recruits Vascular Progenitors to Mitotic Neovasculature, where Microenvironment Influences Their Differentiated PhenotypesCancer Research, 2006
- A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1Neuro-Oncology, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Magnetic Resonance Imaging of the Body Trunk Using a Single-Slab, 3-Dimensional, T2-weighted Turbo-Spin-Echo Sequence With High Sampling Efficiency (SPACE) for High Spatial Resolution ImagingInvestigative Radiology, 2005
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsPublished by Elsevier ,2005
- Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant gliomaCancer, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationCancer Cell, 2004
- Glioblastoma cells block radiation‐induced programmed cell death of endothelial cellsFEBS Letters, 2004